Saturday 17 October 2026 Export ANL’s income statement to Excel — free account

Adlai Nortye Ltd. Sponsored ADR

ANL Healthcare Biotechnology

Adlai Nortye Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.0 million, roughly unchanged from fiscal 2023. Dividend growth for five consecutive years.

11.07 1.02 −8.44%

Follow ANL

Alert me

Market cap: $710.1M
P/E: —
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: −22.05
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+3 more TTM periods Free account	—	0.00%	0.00%	0.00%
ROA Full definition →		—	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		—	—	—	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(155.67)	(151.96)	(129.37)	(115.75)
Capital Expenditures Full definition →		(0.50)	—	(0.60)	—
Other line items
Cash ROIC Full definition →		(137.58%)	(132.58%)	(314.20%)	(24.44%)
Accounts Payable Turnover Full definition →		—	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.64	0.00	0.62	0.00
Capex/Depreciation Full definition →		(0.15)	—	(0.17)	—
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	—	0.00	—
Capex to Sales Full definition →		0.00	—	0.00	—

Show all line items

Columns are period end dates